Clinical Trial Update: Clinical Study on Treatment of Apatinib Mesylate in First-line Maintenance of Advanced Gastric Cancer [NA]

View source ↗

Summary

A clinical trial investigating apatinib mesylate as first-line maintenance therapy for advanced gastric cancer; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib Mesylate (apatinib)

Snippet

Sponsor: DongMa | Conditions: Advanced Gastric Cancer | NA | Status: UNKNOWN